In the advent of Immune Checkpoint inhibitors (ICI) and of CAR-T adoptive T-cells, the new frontier in Oncology is Cancer Immunotherapy because of its ability to provide long term clinical benefit in metastati...
from Cancer via ola Kala on Inoreader https://ift.tt/2HELSKy
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου